Moore Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Hold |
0
| – | – | – | 485 |
|
2023
Q4 | – | Sell |
-20,400
| Closed | -$2.47M | – | 487 |
|
2023
Q3 | $2.47M | Buy |
+20,400
| New | +$2.47M | 0.05% | 193 |
|
2023
Q2 | – | Sell |
-116,819
| Closed | -$16.1M | – | 548 |
|
2023
Q1 | $16.1M | Buy |
116,819
+98,789
| +548% | +$13.6M | 0.34% | 44 |
|
2022
Q4 | $2.34M | Sell |
18,030
-162,030
| -90% | -$21M | 0.06% | 240 |
|
2022
Q3 | $19.9M | Buy |
180,060
+99,760
| +124% | +$11M | 0.47% | 30 |
|
2022
Q2 | $6.02M | Buy |
80,300
+51,622
| +180% | +$3.87M | 0.16% | 126 |
|
2022
Q1 | $2.24M | Buy |
+28,678
| New | +$2.24M | 0.06% | 337 |
|
2019
Q2 | – | Sell |
-7,750
| Closed | -$924K | – | 356 |
|
2019
Q1 | $924K | Sell |
7,750
-4,803
| -38% | -$573K | 0.03% | 226 |
|
2018
Q4 | $1.37M | Buy |
12,553
+7,553
| +151% | +$824K | 0.05% | 151 |
|
2018
Q3 | $808K | Sell |
5,000
-4,000
| -44% | -$646K | 0.02% | 204 |
|
2018
Q2 | $1.19M | Buy |
+9,000
| New | +$1.19M | 0.03% | 179 |
|
2016
Q4 | – | Sell |
-70,000
| Closed | -$4.3M | – | 259 |
|
2016
Q3 | $4.3M | Buy |
+70,000
| New | +$4.3M | 0.15% | 89 |
|